The Food and Drug Administration’s controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency.
Pearsall ISD employee arrested after cocaine packaged for sale found in her home, sheriff’s office saysRecords: Fired SAPD officer was on-duty, left shift early before drunk driving crash28 minutes agoExtra deputies will act as ‘visual deterrence,’ sheriff says‘This was not an easy decision’: SAISD superintendent announces retirementYour weekend plans may be impacted by storms.
Here’s the latest updateFILE - In this undated photo provided by the U.S. Food and Drug Administration, Vinay Prasad smiles for a portrait. FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. FILE - In this undated photo provided by the U.S. Food and Drug Administration, Vinay Prasad smiles for a portrait. announced the news to FDA staff in an email late Friday, saying Prasad would depart at the end of April. Makary said Prasad would return to his academic job at the University of California, San Francisco.In July, Prasad was briefly forced from his job after running afoul of biotech executives, patient groups and conservative allies of President Donald Trump. He was reinstated less than two weeks later with the backing of Health Secretary Robert F. Kennedy Jr. and Makary. Prasad’s latest ouster follows a string of high-profile controversies involving the FDA’s review of vaccines, gene therapies and biotech drugs in which companies have criticized the agency for reversing itself, in some cases calling for new trials of products previously greenlighted by regulators. In the last month, Prasad has come under fire from pharmaceutical executives, investors, members of Congress and other critics for multiple decisions at the agency.made with mRNA technology. The rejection of the application, highly unusual for the FDA, prompted Moderna to go public with Prasad’s decision and vow to formally challenge it.Then, in the past week, the FDA engaged in a highly unusual public fight with a small drug company developing an experimental treatment for Huntington’s Disease, a fatal condition that affects about 40,000 people in the U.S. The company, UniQure, said Monday that the FDA was demanding a new trial of its gene therapy that would involve performing a sham surgery on some of the patients in the trial. The company’s gene therapy is injected directly into the brain during a surgical procedure. Company executives said the request for a sham-controlled trial contradicted previous FDA guidance and raised ethical concerns for patients. On Thursday, the FDA held a highly unusual press conference with reporters to criticize the company’s therapy and defend the agency's request for an additional study. A senior FDA official, who requested anonymity to speak with reporters, called the company’s original study “stone cold negative.”The FDA typically communicates in carefully-vetted written statements when speaking about scientific disagreements, especially those involving experimental drugs that are still under the agency’s review. Prasad’s time as the FDA’s top vaccine and biotech regulator has been marked by a series of similar disputes with the companies the agency regulates. More than a half-dozen drugmakers studying therapies for rare or hard-to-treat diseases have received rejection letters or requests to run additional studies, adding years and potentially many millions of dollars to their development plans.for drug reviews, Prasad’s approach to regulation since arriving at the FDA last May has confounded many FDA observers and critics. On repeated occasions, Prasad joined Makary in announcing steps to make FDA drug reviews faster and easier for companies. But he also has imposed new warnings and study requirements for some biotech drugs and vaccines, particularly COVID shots that have long been a target for Kennedy, a longtime anti-vaccine activist before joining the Trump administration.The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.When will construction on South Alamo Street close?Baptist Health System’s hybrid operating room credited with saving 82-year-old patient’s lifeElection Update on US Rep. Dist. 21New $185 million luxury Hemisfair hotel opens its doorsSan Antonio blood donations needed after Austin mass shooting impacts inventoryWar in Middle East leaves San Antonio family trapped in Israel
Health Marty Makary Washington News Politics Vinay Prasad Donald Trump Robert F. Kennedy Jr. U.S. News
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
California should join states that ban using food stamps for junk foodGovernment-provided food support should be used for healthier fare.
Read more »
More States Restrict SNAP Food Purchases, Targeting Junk FoodSeveral states are implementing restrictions on the types of food SNAP recipients can purchase, banning the use of benefits for junk food items like soda, energy drinks, and candy. This initiative, part of the Make America Healthy Again program, aims to combat chronic diseases and improve the health of Americans.
Read more »
Trump administration's embattled FDA vaccine chief is leaving for the second timeWASHINGTON (AP) — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less
Read more »
Trump administration's embattled FDA vaccine chief is leaving for the second timeThe Food and Drug Administration’s controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency.
Read more »
Controversial FDA vaccine chief Dr. Vinay Prasad exits agency againThe Food and Drug Administration’s controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency. FDA Commissioner Marty Makary announced the departure to staff in an email late Friday.
Read more »
Trump administration’s embattled FDA vaccine chief is leaving for the second timeDr. Vinay Prasad will depart at the end of April, FDA Commissioner Marty Makary said.
Read more »